Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 6—June 2006

Research

Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season

Jeffrey C. Hageman*Comments to Author , Timothy M. Uyeki*, John S. Francis†, Daniel B. Jernigan*, J. Gary Wheeler‡, Carolyn B. Bridges*, Stephen J. Barenkamp§, Dawn M. Sievert¶, Arjun Srinivasan*, Meg C. Doherty†, Linda K. McDougal*, George E. Killgore*, Uri A. Lopatin#, Rebecca Coffman**, J. Kathryn MacDonald††, Sigrid K. McAllister*, Gregory E. Fosheim*, Jean B. Patel*, and L. Clifford McDonald*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; ‡University of Arkansas for Medical Sciences College of Medicine, Little Rock, Arkansas, USA; §Saint Louis University School of Medicine, Saint Louis, Missouri, USA; ¶Michigan Department of Community Health, Lansing, Michigan, USA; #National Institutes of Health, Bethesda, Maryland, USA; **Oklahoma State Department of Health, Oklahoma City, Oklahoma, USA; ††Washington State Department of Health, Shoreline, Washington, USA

Main Article

Table 2

Outcomes of cases of Staphylococcus aureus community-acquired pneumonia associated with influenzalike illness, influenza season 2003–04

Outcome No. (%), N = 17
Hospitalization 16 (94)*
Admitted to ICU† 13 (81)
Required intubation 8 (62)
Chest tube placement 6 (46)
Median length of stay (range) 13 days (1–108)
Death 5 (29)
Median age, y 28 (2–53)
Symptom onset to death, median days (range) 7 (3–73)
Underlying disease 1/5 (20)‡

*One patient died on arrival at the hospital.
†ICU, Intensive care unit.
‡Diabetes.

Main Article

TOP